Severance Agreements in the Biotechnology Industry

437 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
SEVERANCE AGREEMENT AND GENERAL RELEASE
Severance Agreements
RIGEL PHARMACEUTICALS INC
Biotechnology
CA
2016
Chimerix, Inc. Amended and Restated Officer and Severance Benefit Plan
Severance Agreements
CHIMERIX INC
2024
Gilead Sciences, Inc. Severance Plan, amended and restated
Severance Agreements
Gilead Sciences
2024
Executive Severance Plan for Chief-Level Executives
Severance Agreements
Replimune Group, Inc.
2024
Executive Severance Plan, and form of participation agreement thereunder
Severance Agreements
Aura Biosciences, Inc.
2024
Severance Agreement and General Release dated as of August 2, 2024, between Ligand Pharmaceuticals Incorporated and Mr. Korenberg
Severance Agreements
Ligand Pharmaceuticals Incorporated
2024
Confidential Severance Agreement and General Release, effective as of October 9, 2024, by and between Aprea Therapeutics, Inc. and Nadeem Q. Mirza, M.D., M.P.H
Severance Agreements
Aprea Therapeutics, Inc.
2024
Severance Agreement, dated May 22, 2020, by and between Kathleen Goin and Palvella Therapeutics, Inc
Severance Agreements
PIERIS PHARMACEUTICALS, INC.
2024
Severance Agreement, dated May 22, 2020, by and between Kathleen A. McGowan and Palvella Therapeutics, Inc
Severance Agreements
PIERIS PHARMACEUTICALS, INC.
2024
Executive Severance Policy of Adaptimmune Therapeutics plc dated March 10, 2017 and amended and restated effective as of June 11, 2024 and on July 16, 2024
Severance Agreements
Adaptimmune Therapeutics PLC
2024
Executive Severance Policy of Adaptimmune Therapeutics plc dated March 10, 2017 and amended and restated effective as of June 11, 2024
Severance Agreements
Adaptimmune Therapeutics PLC
2024
iBio, Inc. Officer Severance Benefit Plan, effective May 9, 2024
Severance Agreements
iBio, Inc.
2024
Executive Severance Plan
Severance Agreements
Natera, Inc.
2024
Severance Agreement dated March 21, 2024 between Y-mAbs Therapeutics A/S and Steen Lisby
Severance Agreements
Y-mAbs Therapeutics, Inc.
2024
Form of Officer Executive Severance Agreement (Reflecting Clawback Policy)
Severance Agreements
Akebia Therapeutics, Inc.
2024
Participation Agreement under Severance Plan for Michael Sumner
Severance Agreements
INOVIO PHARMACEUTICALS, INC.
2024
Participation Agreement under Severance Plan for Laurent Humeau
Severance Agreements
INOVIO PHARMACEUTICALS, INC.
2024
Participation Agreement under Severance Plan for Jacqueline Shea
Severance Agreements
INOVIO PHARMACEUTICALS, INC.
2024
Inovio Pharmaceuticals, Inc. Severance Plan and Summary Plan Description
Severance Agreements
INOVIO PHARMACEUTICALS, INC.
2024
Severance Benefits Policy for Senior Vice Presidents and Vice Presidents
Severance Agreements
ARYA Sciences Acquisition Corp II
2024
Severance Benefits Policy for Specified C-Suite Executives
Severance Agreements
ARYA Sciences Acquisition Corp II
2024
Arcus Biosciences, Inc. Severance Benefits Plan
Severance Agreements
Arcus Biosciences, Inc.
2024
Severance Policy
Severance Agreements
HALOZYME THERAPEUTICS INC
2024
Severance Agreement, between the registrant and Cenk Sumen
Severance Agreements
MAXCYTE, INC.
2024
Form of Severance Agreement
Severance Agreements
Aeglea BioTherapeutics, Inc.
2023
Amended and Restated Severance Benefits Plan
Severance Agreements
Editas Medicine, Inc.
2023
Form of Severance Agreement
Severance Agreements
Aeglea BioTherapeutics, Inc.
2023
Severance agreement between the Registrant and Eva Ehrnrooth, dated August 10, 2023
Severance Agreements
IO Biotech, Inc.
2023
Executive Severance Plan, as amended
Severance Agreements
RIGEL PHARMACEUTICALS INC
2023
Severance Policy for Senior Vice Presidents and Vice Presidents, dated October 11, 2022, by and between Mirati Therapeutics, Inc. and Aaron A. Ondrey
Severance Agreements
Mirati Therapeutics, Inc.
2023
Cytokinetics, Incorporated Executive Severance Plan and Summary Plan Description
Severance Agreements
Cytokinetics, Incorporated
2023
Mirum Pharmaceuticals, Inc. Amended and Restated Severance Benefit Plan and form of Participation Agreement thereunder
Severance Agreements
Mirum Pharmaceuticals, Inc.
2023
Form of Management Continuity and Severance Agreement between Company and certain of its executive officers
Severance Agreements
DYNAVAX TECHNOLOGIES CORP
2023
Second Amendment to Calyxts 2021 Executive Severance Plan
Severance Agreements
Calyxt, Inc.
2023
Amendment No. 2 to Severance Agreement by and between James Fong and CTI BioPharma Corp
Severance Agreements
CTI BIOPHARMA CORP
2023
Severance Agreement, dated March 27, 2023, by and between the Registrant and Robert Francomano
Severance Agreements
SELLAS Life Sciences Group, Inc.
2023
Amendment to the Vaxart, Inc. Severance Benefit Plan dated May 2, 2023
Severance Agreements
Vaxart, Inc.
2023
Confidential Severance Agreement and General Release between Aprea Therapeutics, Inc. and Scott M. Coiante
Severance Agreements
Aprea Therapeutics, Inc.
Biotechnology
DE
2023
Severance Agreement, dated March 27, 2023, by and between the registrant and Douglas J. Swirsky
Severance Agreements
MAXCYTE, INC.
Biotechnology
MD
2023
Severance Agreement between Globalization Partners Switzerland SA and Nicola Heffron, dated February 17, 2023
Severance Agreements
2seventy bio, Inc.
Biotechnology
2023
Severance Agreement, dated February 13, 2023, by and between Evelo Biosciences, Inc. and Jonathan Zung
Severance Agreements
Evelo Biosciences, Inc.
Biotechnology
MA
2023